Seres Therapeutics (MCRB) Operating Leases (2019 - 2026)
Seres Therapeutics' Operating Leases was $44.82 million in Q2 2026, down 42.5% from $77.96 million a year earlier and down 35.6% from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Seres Therapeutics came in at $72.58 million, down 12.5% from FY2024.
- Operating Leases has now declined for three consecutive years, though with a five-year compound annual growth rate of 47.0% (FY2020 to FY2025).
- In earlier years, Operating Leases was $82.97 million in FY2024 (-9.5%), $91.65 million in FY2023 (-15.1%), $107.94 million in FY2022 (+501.1%) and $17.96 million in FY2021 (+70.0%).
- The Q2 2026 figure marks the lowest quarterly Operating Leases since Q3 2022.
- Compared with a year earlier, Operating Leases has declined for 11 straight quarters, with an average decline of 19.2% over the last eight quarters.
- The best year-over-year quarter for Operating Leases over five years was Q4 2022 (growth of 501.1%); the worst was Q2 2026 (a decline of 42.5%).
- Per Business Quant data, MCRB's Operating Leases in the three quarters before Q2 2026 was $69.63 million (Q1 2026), $72.58 million (Q4 2025) and $75.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,129.39 Bn | 1,097.98 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.68 Bn | 534.21 Bn | 17.26 Bn |
| 3 | AbbVie | 505.77 Bn | 478.89 Bn | 12.70 Bn |
| 4 | Merck | 366.50 Bn | 320.88 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.33 Bn | 261.32 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.02 Bn | 234.71 Bn | 12.86 Bn |
| 7 | Amgen | 235.47 Bn | 190.87 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 189.20 Bn | 163.40 Bn | 6.22 Bn |
| 9 | Pfizer | 170.20 Bn | 116.85 Bn | 10.94 Bn |
| 10 | Seres Therapeutics | 23.29 Mn | -115.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.82 Mn |
| Mar 31, 2026 | 69.63 Mn |
| Dec 31, 2025 | 72.58 Mn |
| Sep 30, 2025 | 75.33 Mn |
| Jun 30, 2025 | 77.96 Mn |
| Mar 31, 2025 | 80.50 Mn |
| Dec 31, 2024 | 82.97 Mn |
| Sep 30, 2024 | 85.27 Mn |
| Jun 30, 2024 | 100.94 Mn |
| Mar 31, 2024 | 103.34 Mn |
| Dec 31, 2023 | 91.65 Mn |
| Sep 30, 2023 | 104.86 Mn |
| Jun 30, 2023 | 106.71 Mn |
| Mar 31, 2023 | 106.69 Mn |
| Dec 31, 2022 | 107.94 Mn |
| Sep 30, 2022 | 17.85 Mn |
| Jun 30, 2022 | 19.52 Mn |
| Mar 31, 2022 | 20.35 Mn |
| Dec 31, 2021 | 17.96 Mn |
| Sep 30, 2021 | 12.23 Mn |
API Access
Seres Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();